Industry
Biotechnology
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Loading...
Open
44.16
Mkt cap
439M
Volume
93K
High
47.23
P/E Ratio
-5.51
52-wk high
98.00
Low
41.14
Div yield
N/A
52-wk low
30.00
Portfolio Pulse from Benzinga Newsdesk
October 21, 2024 | 1:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 21, 2024 | 1:22 pm
Portfolio Pulse from Benzinga Newsdesk
October 18, 2024 | 11:00 am
Portfolio Pulse from Benzinga Insights
October 16, 2024 | 4:31 pm
Portfolio Pulse from Avi Kapoor
October 16, 2024 | 2:23 pm
Portfolio Pulse from Benzinga Newsdesk
September 19, 2024 | 2:09 pm
Portfolio Pulse from Vandana Singh
September 18, 2024 | 7:30 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.